1Institute of Metabolism and Cell Death, Helmholtz Zentrum München, Neuherberg, Germany.
2Transplant Center, University Hospital Munich, Ludwig-Maximilians-University (LMU), Munich, Germany.
3Department of Medicine 2 (Nephrology, Rheumatology, Clinical Immunology and Hypertension), Medical Faculty, RWTH Aachen University, Aachen, Germany.
4Center of Excellence in Nephrology, University Hospitals of Aachen, Cologne and Dusseldorf, Aachen, Germany.
5Clinical Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
6Molecular Signaling and Cell Death Unit, VIB-UGent Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, Belgium.
7Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
8Krantz Family Center for Cancer Research and Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
9Department of Medicine, Harvard Medical School, Boston, MA, USA.
10Department of Molecular Metabolism, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
11MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.
12Translational Redox Biology, Natural School of Sciences, Technical University of Munich, Garching, Germany.
13Department of Medicine 2 (Nephrology, Rheumatology, Clinical Immunology and Hypertension), Medical Faculty, RWTH Aachen University, Aachen, Germany. rkramann@gmx.net.
14Center of Excellence in Nephrology, University Hospitals of Aachen, Cologne and Dusseldorf, Aachen, Germany. rkramann@gmx.net.
15Department of Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands. rkramann@gmx.net.